| Metric | FY2025 | FY2024 |
|---|---|---|
| Research and development | $42.4M+126.5% | $18.7M |
| General and administrative | $15.8M-10.9% | $17.7M |
| Change in estimate for legal contingencies | $0+100.0% | -$4.2M |
| Income from insurance recovery | $0+100.0% | -$2.0M |
| Total operating expenses | $58.2M+92.6% | $30.2M |
| Operating loss | -$58.2M-92.6% | -$30.2M |
| Interest expense | $0-100.0% | $749K |
| Interest income | $1.9M-37.8% | $3.0M |
| Gain from asset sale | -$361K+73.4% | -$1.4M |
| Other expense | $502-77.2% | $2K |
| Total other (income) expense, net | -$2.2M+38.3% | -$3.6M |
| Loss before income taxes | -$55.9M-110.6% | -$26.6M |
| Provision for income taxes | $5K-46.4% | $10K |
| Net loss | -$55.9M-110.5% | -$26.6M |
| Basic (in dollars per share) | -$1.41-93.2% | -$0.73 |
| Diluted (in dollars per share) | -$1.41-93.2% | -$0.73 |
| Basic (in shares) | 39.7M+8.7% | 36.5M |
| Diluted (in shares) | 39.7M+8.7% | 36.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.